ShanXi C&Y Pharmaceutical Group Co.,LTD. (SHE:300254)
13.50
+0.69 (5.39%)
Apr 30, 2026, 3:08 PM CST
55.71% (1Y)
| Market Cap | 3.46B +39.1% |
| Revenue (ttm) | 849.26M +1.6% |
| Net Income | 20.36M -75.5% |
| EPS | 0.08 -75.8% |
| Shares Out | 256.06M |
| PE Ratio | 162.05 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 24,406,461 |
| Average Volume | 15,805,083 |
| Open | 11.82 |
| Previous Close | 12.81 |
| Day's Range | 11.82 - 13.64 |
| 52-Week Range | 8.58 - 14.23 |
| Beta | 0.48 |
| RSI | 68.22 |
| Earnings Date | Apr 28, 2026 |